Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,517 | -27,426 | -17,560 | -79,979 | -61,322 |
| Accounts payable and accrued liabilities | -2,678 | -2,769 | -2,866 | 625 | -1,161 |
| Other Working Capital | -4,966 | -4,717 | -4,767 | -1,579 | -4,474 |
| Other Operating Activity | 13,971 | 10,443 | 7,125 | 29,178 | 24,001 |
| Operating Cash Flow | $-31,191 | $-24,469 | $-18,067 | $-51,756 | $-42,956 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,791 | 22,038 | 15,360 | 51,562 | 40,216 |
| Investing Cash Flow | $28,791 | $22,038 | $15,360 | $51,562 | $40,216 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 0 | 247 | 247 |
| Other Financing Activity | -73 | -73 | 0 | -287 | -115 |
| Financing Cash Flow | $-73 | $-73 | $0 | $-40 | $132 |
| Beginning Cash Position | 3,857 | 3,857 | 3,857 | 4,092 | 4,092 |
| End Cash Position | 1,385 | 1,353 | 1,150 | 3,857 | 1,484 |
| Net Cash Flow | $-2,473 | $-2,504 | $-2,707 | $-235 | $-2,608 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,191 | -24,469 | -18,067 | -51,756 | -42,956 |
| Free Cash Flow | -31,191 | -24,469 | -18,067 | -51,756 | -42,956 |